CompletedNot Applicable

HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)

United States159 participantsStarted 2014-06-23

Plain-language summary

STRIDE2 is a longitudinal, non-randomized study of individuals living with HIV who are dependent on opioids. This study is funded by the National Institute on Drug Abuse (R01DA030768, Altice, PI; Taxman \& Lawson, Co-PIs) and is being conducted by George Mason University, Yale University, and Howard University.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. HIV+, confirmed by rapid HIV test
✓. Meet DSM-IV criteria for opioid dependence
✓. 18 years or older
✓. Have health insurance that is accepted at Lab Corp.

Exclusion criteria

✕. Are \<18 years old;
✕. Are HIV negative;
✕. Are Unable to communicate in English;
✕. Are not able to provide informed consent;
✕. Do not meet DSM-IV criteria for opioid dependence;
✕. Plan to leave the DC area

What they're measuring

VL <400

Timeframe: Month 0

CD4+ cell count

Timeframe: Month 0

VL <400

Timeframe: 6 months

CD4+ cell count

Timeframe: 6 months

VL <400

Timeframe: 12 months

CD4+ cell count

Timeframe: 12 months

Trial details

NCT IDNCT03583138

SponsorYale University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2015-12-15

View on ClinicalTrials.gov More Human Immunodeficiency Virus trials